Collplant Biotechnologies Ltd (CLGN) Stock Analysis

Collplant Biotechnologies Ltd (CLGN) is a publicly traded company in the HEALTHCARE sector. It trades at $0.40, carries a market capitalization of $5.78M. This page summarizes the public market data, fundamentals, and frequently asked questions for CLGN, with GNG Research's proprietary safety, quality, and valuation analysis available to members.

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NASDAQ

Key Metrics

• Price: $0.40
• Market Cap: $5.78M
• EPS: $-1.04
• 52-Week High: $3.23
• 52-Week Low: $0.27

Market Sentiment

Collplant Biotechnologies Ltd currently has a Bearish sentiment score of -0.28.

About Collplant Biotechnologies Ltd

CollPlant Biotechnologies Ltd. is a pioneering company at the forefront of aesthetic and regenerative medicine, based in Rehovot, Israel, with a strong presence in key markets including the United States, Canada, and Europe. The company specializes in cutting-edge three-dimensional (3D) bioprinting technologies for creating tissues and organs, leveraging its proprietary collagen-based solutions to transform treatment modalities in these fields. By advancing medical aesthetics and regenerative...

GNG Research Analysis

GNG Research scores Collplant Biotechnologies Ltd (CLGN) on three proprietary dimensions — a Safety score, a Quality score, and a Valuation score — alongside fair value estimates and buy-price targets for 5,000+ companies. These ratings are reserved for members. Read how the scores are calculated on our methodology page, or see GNG Research plans to unlock the full rating for CLGN.

Frequently Asked Questions

Does CLGN pay dividends?

Collplant Biotechnologies Ltd (CLGN) does not currently pay a regular dividend.

What is CLGN's market cap?

Collplant Biotechnologies Ltd (CLGN) has a market capitalization of $5.78M with a current stock price of $0.40.